From Administration of Oral Medicines by Nurses to Controlled Self-administration: Impact on Safety of Administration During Hospitalisation (AUTOGESTMED)

October 11, 2024 updated by: Centre Hospitalier de Valenciennes

Evaluation of the Safety of a Change of Practice in the Administration of Oral Medication During Hospitalisation: From Administration by the Nurse to Supervision of Self-administration of Medication in the Locomotor and Polyvalent Rehabilitation Department of the Valenciennes Hospital Centre.

Medication administration practices during patient hospital stay tend to improve patient autonomy. Several studies have concluded that self-administration of medication programs in hospital centers have a beneficial effect on patients' knowledge of their medications, their compliance and the safety of administration. Nevertheless, few studies have been carried out in France on this subject. The aim of this study is to evaluate the impact of the change of nurses administration practices from the administration of each drugs to supervision of self-administration by the patient under a self-administration program.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

192

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Valenciennes, France, 59300
        • Recruiting
        • Ch Valenciennes
        • Contact:
        • Principal Investigator:
          • Quentin HIVER

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Care in the rehabilitation unit of Hospital in Valenciennes, France
  • Patient with a planned stay of 7 days or more
  • Patient on chronic treatment before admission to hospital ;
  • Patients taking their treatment alone at home;

Exclusion Criteria:

  • Age < 18 years old
  • Patients with poor compliance
  • No chronic treatment
  • Unstable disease
  • Major cognitive, memory or depressive disorders
  • Swallowing disorders
  • Prehension problems
  • Patient under legal protection
  • Patient under guardianship or curatorship
  • Patient included in another trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Self administration of medication by the patient
Management of drugs' administration by the patient
No Intervention: Administration of medication by the nurses
Administration of medication by the nurses during medication administration rounds

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total number of oral medication administration errors in self-administered patients
Time Frame: After 7 days of self-administration
Total number of oral medication administration errors in self-administered patients
After 7 days of self-administration
Total number of oral medication administration errors in patients receiving administration by nurses
Time Frame: After 7 days of administration by nurses
Total number of oral medication administration errors in patients receiving administration by nurses
After 7 days of administration by nurses

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication compliance in self-managed patients
Time Frame: At the beginning of the study

Medication compliance is assessed using the questionnaire "Evaluation of medication compliance" provided by the French health insurance system.

This questionnaire consists of 6 questions with "yes" or "no" answers. Each "no" answer is worth 1 point, each "yes" answer is worth 0 points. A patient with poor medication compliance will have a score of 3 or less.

At the beginning of the study
Medication compliance in self-managed patients
Time Frame: 15 days after hospital discharge for self-managed patients

Medication compliance is assessed using the questionnaire "Evaluation of medication compliance" provided by the French health insurance system.

This questionnaire consists of 6 questions with "yes" or "no" answers. Each "no" answer is worth 1 point, each "yes" answer is worth 0 points. A patient with poor medication compliance will have a score of 3 or less.

15 days after hospital discharge for self-managed patients
Patient satisfaction with self-administration of oral medication
Time Frame: Within 24 hours of discharge from hospital

Patient satisfaction was assessed using a questionnaire designed by the investigator, consisting of 9 questions giving a total of 45 points.

The higher the total, the higher the level of satisfaction.

Within 24 hours of discharge from hospital
Care staff satisfaction with self-administration
Time Frame: 6 months after the beginning of the study

Care staff satisfaction was assessed using a questionnaire designed by the investigator, consisting of 4 questions totalling 20 points.

The higher the total, the higher the level of satisfaction.

6 months after the beginning of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Quentin HIVER, PH, Centre Hospitalier de Valenciennes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2024

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

September 5, 2024

First Submitted That Met QC Criteria

October 11, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 11, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-02-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self Administration

Clinical Trials on Self-administration medicines

Subscribe